Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Lachowiez, Curtis [1 ]
Takahashi, Koichi [2 ]
Loghavi, Sanam [3 ]
Xiao, Lianchun [4 ]
Kadia, Tapan [2 ]
Adeoti, Maria [2 ]
Short, Nicholas [2 ]
Sasaki, Koji [2 ]
Wang, Sa [3 ]
Borthakur, Gautam [2 ]
Issa, Ghayas [2 ]
Maiti, Abhishek [2 ]
Alvarado, Yesid [2 ]
Pemmaraju, Naveen [2 ]
Bravo, Guillermo Montalban [2 ]
Masarova, Lucia [2 ]
Yilmaz, Musa [2 ]
Jain, Nitin [2 ]
Andreeff, Michael [2 ]
Jabbour, Elias [2 ]
Garcia-Manero, Guillermo [2 ]
Kornblau, Steven [2 ]
Ravandi, Farhad [2 ]
Konopleva, Marina [2 ]
Kantarjian, Hagop [2 ]
DiNardo, Courtney [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
induction chemotherapy; venetoclax; targeted therapy; acute myeloid leukemia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-204
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [41] A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia
    Bang, Su-Yeon
    Park, Silvia
    Kwag, Daehun
    Lee, Jong Hyuk
    Min, Gi-June
    Park, Sung-Soo
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    CANCERS, 2023, 15 (06)
  • [42] Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
    Liu, Qingyang
    Yang, Jingjing
    Lv, Lei
    Zhang, Xiawei
    Li, Meng
    Xu, Lingmin
    Huang, Sai
    Jing, Yu
    Dou, Liping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [43] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Patrick K. Reville
    Tapan Kadia
    Current Treatment Options in Oncology, 2020, 21
  • [44] Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax plus Hypomethylating Agent
    Gangat, Naseema
    Elbeih, Azeem
    Ghosoun, Nour
    Mccullough, Kristen
    Aperna, Fnu
    Johnson, Isla M.
    Abdelmagid, Maymona
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Elliott, Michelle
    Mangaonkar, Abhishek
    Matin, Aasiya
    Saliba, Antoine N.
    Torghabeh, Mehrdad Hefazi
    Litzow, Mark R.
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Badar, Talha
    Murthy, Hemant
    Foran, James
    Palmer, Jeanne
    Sproat, Lisa
    Khera, Nandita
    Yi, Cecilia Arana
    Yates, Samuel
    Sneider, Abigail
    Dworkin, Emily
    Patel, Anand A.
    Bazinet, Alexandre
    Senapati, Jayastu
    Bataller, Alex
    Dinardo, Courtney
    Kadia, Tapan
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (02) : 260 - 271
  • [45] A Phase 1 Study of Gilteritinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Final Study Results
    Pratz, Keith W.
    Cherry, Mohamad
    Podoltsev, Nikolai A.
    Altman, Jessica K.
    Perl, Alexander E.
    Cooper, Brenda W.
    Jurcic, Joseph G.
    Lin, Tara L.
    Schiller, Gary J.
    Wu, Ruishan
    Hill, Jason E.
    Gill, Stanley C.
    James, Angela
    Rich, Elizabeth Shima
    Hasabou, Nahla
    Levis, Mark J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S230 - S230
  • [46] Leukapheresis in patients newly diagnosed with acute myeloid leukemia
    Villgran, Vipin
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Lim, Seah H.
    Redner, Robert L.
    Im, Annie
    Sehgal, Alison
    Dorritie, Kathleen A.
    Kiss, Joseph E.
    Normolle, Daniel
    Boyiadzis, Michael
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 55 (02) : 216 - 220
  • [47] Venetoclax in acute myeloid leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 271 - 276
  • [48] Low-dose venetoclax combined with azacitidine in older and frail patients with newly diagnosed acute myeloid leukaemia
    Rong, Chunmeng
    Yang, Fang
    Chen, Yalu
    Wang, Ming
    Ai, Cheng
    Luo, Yuqing
    Gao, Panpan
    Weng, Yiqin
    Huang, Xiaguang
    Gu, Meier
    Huang, Weiping
    Xia, Yongming
    ONCOLOGY LETTERS, 2024, 27 (05)
  • [49] Fate of Patients with Newly Diagnosed Acute Myeloid Leukemia Who Fail Primary Induction Therapy
    Othus, Megan
    Appelbaum, Frederick R.
    Petersdorf, Stephen H.
    Kopecky, Kenneth J.
    Slovak, Marilyn
    Nevin, Thomas
    Brandwein, Joseph
    Larson, Richard A.
    Stiff, Patrick J.
    Walter, Roland B.
    Tallman, Martin S.
    Stenke, Leif
    Erba, Harry P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 559 - 574
  • [50] Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia
    Miranti, Eugenia
    Ho, Dora Y.
    Enriquez, Kyle
    Subramanian, Aruna K.
    Medeiros, Bruno C.
    Epstein, David J.
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2206 - 2212
12345